Dana-Farber Cancer Institute, Inc. ;President and Fellows of Harvard College
发明人:
Haining William N.,Sharpe Arlene H.,Godec Jernej
申请号:
US201515518860
公开号:
US2017233808(A1)
申请日:
2015.10.16
申请国别(地区):
美国
年份:
2017
代理人:
摘要:
The present invention is based on the identification, of compositions and methods for the identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators.